| Metadato | Etiqueta | Valor | Idioma |
|---|---|---|---|
| dc.contributor.author | Autor | Farge, Dominique | - |
| dc.contributor.author | Autor | Frere, Corinne | - |
| dc.contributor.author | Autor | Connors, Jean M. | - |
| dc.contributor.author | Autor | Khorana, Alok A. | - |
| dc.contributor.author | Autor | Kakkar, Ajay | - |
| dc.contributor.author | Autor | Ay, Cihan | - |
| dc.contributor.author | Autor | Muñoz, Andrés | - |
| dc.contributor.author | Autor | Brenner, Benjamin | - |
| dc.contributor.author | Autor | Prata, Pedro H. | - |
| dc.contributor.author | Autor | Brilhante, Dialina | - |
| dc.contributor.author | Autor | Antic, Darko | - |
| dc.contributor.author | Autor | Casais, Patricia | - |
| dc.contributor.author | Autor | Guillermo Espósito, María Cecilia | - |
| dc.contributor.author | Autor | Ikezoe, Takayuki | - |
| dc.contributor.author | Autor | Abutalib, Syed A. | - |
| dc.contributor.author | Autor | Meillon García, Luis A. | - |
| dc.contributor.author | Autor | Bounameaux, Henri | - |
| dc.contributor.author | Autor | Pabinger, Ingrid | - |
| dc.contributor.author | Autor | Douketis, James | - |
| dc.contributor.author | Autor | International Initiative on Thrombosis and Cancer (ITAC) advisory panel | - |
| dc.contributor.filiacion | Filiación | Farge Dominique, Nord-Université de Paris (Francia). Faculté de Médecine, Institut de Recherche St-Louis | - |
| dc.contributor.filiacion | Filiación | Frere Corinne, Sorbonne Université (Francia). Assistance Publique Hôpitaux de Paris | - |
| dc.contributor.filiacion | Filiación | Connors Jean M., Harvard Medical School (E.E:U.U.). Brigham and Women's Hospital, Hematology Division | - |
| dc.contributor.filiacion | Filiación | Khorana Alok A., Cleveland Clinic (E.E:U.U.). Taussig Cancer Institute and Case Comprehensive Cancer Center | - |
| dc.contributor.filiacion | Filiación | Kakkar Ajay, University College London (Reino Unido). Faculty of Medical Sciences. Thrombosis Research Institute | - |
| dc.contributor.filiacion | Filiación | Ay Cihan, University of Vienna (Austria). Department of Medicine. Clinical Division of Hematology and Hemostaseology | - |
| dc.contributor.filiacion | Filiación | Muñoz Andrés, Universidad Complutense (España). Hospital General Universitario Gregorio Marañón. Departamento de Oncología Médica | - |
| dc.contributor.filiacion | Filiación | Brenner Benjamin, Rambam Health Care Campus (Israel). Department of Hematology and Bone Marrow Transplantation | - |
| dc.contributor.filiacion | Filiación | Prata Pedro H., Nord-Université de Paris (Francia). Hôpital Saint-Louis, Assistance Publique Hôpitaux de Paris, Service d'Hématologie et Transplantation | - |
| dc.contributor.filiacion | Filiación | Brilhante Dialina, Instituto Português de Oncologia de Lisboa Francisco Gentil (Portugal). | - |
| dc.contributor.filiacion | Filiación | Antic Darko, University of Belgrade (Serbia). Clinic for Hematology, Clinical Center Serbia | - |
| dc.contributor.filiacion | Filiación | Casais Patricia, Universidad de Buenos, Buenos Aires (Argentina). Instituto de Investigaciones en Salud Pública | - |
| dc.contributor.filiacion | Filiación | Guillermo Espósito María Cecilia, Universidad de la República (Uruguay). Facultad de Medicina. Hospital de Clínicas, Departamento Clínico de Medicina | - |
| dc.contributor.filiacion | Filiación | Ikezoe Takayuki, Fukushima Medical University (Japoón). Department of Hematology, | - |
| dc.contributor.filiacion | Filiación | Abutalib Syed A., Cancer Treatment Centers of America (E.E:U.U.) | - |
| dc.contributor.filiacion | Filiación | Meillon García Luis A., Centro Médico ABC (México) | - |
| dc.contributor.filiacion | Filiación | Bounameaux Henri, University of Geneva (Suiza). Faculty of Medicine | - |
| dc.contributor.filiacion | Filiación | Pabinger Ingrid, University of Vienna (Austria). Department of Medicine. Clinical Division of Hematology and Hemostaseology | - |
| dc.contributor.filiacion | Filiación | Douketis James, McMaster University (Canadá). Department of Medicine | - |
| dc.contributor.filiacion | Filiación | International Initiative on Thrombosis and Cancer (ITAC) advisory panel, Autor corporativo | - |
| dc.date.accessioned | Fecha ingreso | 2026-05-12T17:37:39Z | - |
| dc.date.available | Fecha disponible | 2026-05-12T17:37:39Z | - |
| dc.date.issued | Año de publicación | 2022 | - |
| dc.description | Descripción | Collaborators International Initiative on Thrombosis and Cancer (ITAC) advisory panel: Walter Ageno, Fernando Ajauro, Thierry Alcindor, Pantep Angchaisuksiri, Juan I Arcelus, Raquel Barba, Ali Bazarbachii, Audrey Bellesoeur, Okba Bensaoula, Ilham Benzidia, Darius Bita, Viktoria Bitsadze, Dorit Blickstein, Mark Blostein, Isabel Bogalho, Antonio Brandao, Rodrigo Calado, Antoine Carpentier, Jose Manuel Ceresetto, Rufaro Chitsike, Jérôme Connault, Catarina Jacinto Correia, Benjamin Crichi, Erich V De Paula, Ahmet M Demir, Laure Deville, Ludovic Doucet, Vera Dounaevskaia, Cécile Durant, Martin Ellis, Joseph Emmerich, Anna Falanga, Carme Font, Enrique Gallardo, Thomas Gary, Filipe Gonçalves, Jean-Christophe Gris, Hiromi Hayashi, Adrian Hij, Luis Jara-Palomares, David Jiménez, Jamilya Khizroeva, Michel N'Guessan, Florian Langer, Claire Le Hello, Christine Le Maignan, Ramón Lecumberri, Lai Heng Lee, Zachary Liederman, Luisa Lopes Dos Santos, Duarte Henrique Machado, Alexander Makatsariya, Alberto Maneyro, Zora Marjanovic, Serban Milhaileanu, Manuel Monreal, Sara Morais, Antonio Moreira, Mikio Mukai, Arlette Ndour, Luciana Correa Oliveira, Remedios Otero-Candelara, Maria Carolina Tostes Pintao, Florian Posch, Pascal Prilollet, Hanadi Rafii, Daniel Dias Ribeiro, Hanno Riess, Marc Righini, Helia Robert-Ebadi, Cynthia Rothschild, Andre Roussin, José Antonio Rueda Camino, Pedro Ruiz-Artacho, Gleb Saharov, Joana Santos, Maxime Sebuhyan, Ali Shamseddine, Galia Spectre Spectre, Ali Taher, Javier Trujillo-Santos, Inna Tzoran, Stéphane Villiers, Raymond Wong, Yugo Yamashita, Alexandra Yannoutsos, Chikao Yasuda. | es |
| dc.description.abstract | Resumen | The International Initiative on Thrombosis and Cancer is an independent academic working group of experts aimed at establishing global consensus for the treatment and prophylaxis of cancer-associated thrombosis. The 2013, 2016, and 2019 International Initiative on Thrombosis and Cancer clinical practice guidelines have been made available through a free, web-based mobile phone application. The 2022 clinical practice guidelines, which are based on a literature review up to Jan 1, 2022, include guidance for patients with cancer and with COVID-19. Key recommendations (grade 1A or 1B) include: (1) low-molecular-weight heparins (LMWHs) for the initial (first 10 days) treatment and maintenance treatment of cancer-associated thrombosis; (2) direct oral anticoagulants for the initial treatment and maintenance treatment of cancer-associated thrombosis in patients who are not at high risk of gastrointestinal or genitourinary bleeding, in the absence of strong drug-drug interactions or of gastrointestinal absorption impairment; (3) LMWHs or direct oral anticoagulants for a minimum of 6 months to treat cancer-associated thrombosis; (4) extended prophylaxis (4 weeks) with LMWHs to prevent postoperative venous thromboembolism after major abdominopelvic surgery in patients not at high risk of bleeding; and (5) primary prophylaxis of venous thromboembolism with LMWHs or direct oral anticoagulants (rivaroxaban or apixaban) in ambulatory patients with locally advanced or metastatic pancreatic cancer who are treated with anticancer therapy and have a low risk of bleeding. | es |
| dc.format.extent | Extensión | 15 p. | es |
| dc.format.mimetype | Formato | application/pdf | es |
| dc.identifier.citation | Citación | Farge D, Frere C, Connors J y otros. 2022 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer, including patients with COVID-19. The Lancet Oncology [en línea]. 2022;23(7):334-347 | es |
| dc.identifier.doi | DOI | 10.1016/S1470-2045(22)00160-7 | - |
| dc.identifier.eissn | e-ISSN | 1474-5488 | - |
| dc.identifier.uri | URI | https://hdl.handle.net/20.500.12008/54966 | - |
| dc.language.iso | Idioma | en | es |
| dc.publisher | Editorial | Elsevier | es |
| dc.relation.ispartof | EN | The Lancet Oncology. 2022;23(7):334-347 | es |
| dc.rights | Derechos | Las obras depositadas en el Repositorio se rigen por la Ordenanza de los Derechos de la Propiedad Intelectual de la Universidad de la República.(Res. Nº 91 de C.D.C. de 8/III/1994 – D.O. 7/IV/1994) y por la Ordenanza del Repositorio Abierto de la Universidad de la República (Res. Nº 16 de C.D.C. de 07/10/2014) | es |
| dc.rights.licence | Licencia | Licencia Creative Commons Atribución (CC - By 4.0) | es |
| dc.subject.other | Descriptores | GUÍA DE PRÁCTICA CLÍNICA | es |
| dc.subject.other | Descriptores | COVID-19 | es |
| dc.subject.other | Descriptores | NEOPLASIAS | es |
| dc.subject.other | Descriptores | TROMBOEMBOLIA VENOSA | es |
| dc.subject.other | Descriptores | PREVENCIÓN DE ENFERMEDADES | es |
| dc.subject.other | Descriptores | TERAPÉUTICA | es |
| dc.title | Título | 2022 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer, including patients with COVID-19 | es |
| dc.type | Tipo de documento | Artículo | es |
Colecciones:
| Ficheros | Descripción | Tamaño | Formato | ||
|---|---|---|---|---|---|
| 2022 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism.pdf | 2022 international clinical practice guidelines | 5.84 MB | Adobe PDF |